Citi downgrades Man Group stock to Neutral on weak AHL strategy performance

Citi downgraded Man Group Plc. to Neutral and reduced its price target to GBP1.85 from GBP2.65, citing persistent weak performance in key high-margin AHL strategies. This concern stems from the expectation that performance fees from these strategies will not materialize until 2027, leading Citi to project 2025-2027 earnings estimates approximately 20% below consensus and diminishing the immediate investment appeal despite the stock's non-demanding valuation.

Analysis

Citigroup has downgraded Man Group Plc. (EMG) to Neutral from Buy and sharply reduced its price target to GBP1.85 from GBP2.65, signaling significant concerns over the firm's core profitability drivers. The downgrade is predicated on the persistent weak performance of Man Group's high-margin AHL strategies, which has contributed to the stock's approximate 20% year-to-date decline, a stark underperformance against Citi's European Diversified Financials coverage benchmark, which is up 5%. Critically, Citi projects that these key strategies will fail to generate performance fees until 2027. This forecast places Citi's earnings estimates for fiscal years 2025-2027 approximately 20% below consensus, suggesting a substantial risk of future earnings disappointments. While Citi acknowledges that Man Group's valuation is not demanding and offers optionality on a performance recovery, the immediate downside risk to consensus estimates is deemed to outweigh the potential reward, reducing the urgency for investors to build a position.

Key Decisions for Investors

• Investors should brace for potential downward revisions to consensus earnings estimates for Man Group for fiscal years 2025-2027, as Citi's forecast is already 20% below the street due to a weak performance fee outlook.
• The primary catalyst for a share price recovery is a turnaround in the AHL strategies; therefore, closely monitor their monthly and quarterly performance metrics and net fund flows for any early signs of improvement.
• Given the stock's negative momentum and the risk to near-term earnings, a neutral stance may be warranted, as the non-demanding valuation is offset by the lack of an immediate catalyst for a re-rating.